Brief: Anika Therapeutics Q2 Revenue USD 44.302 Million
08/08/2023 21:06
Aug 08 (Reuters) - Anika Therapeutics Q2 gross profit USD 28.972 million. * Q2 income from operations USD -3.631 million * Q2 net income USD -2.741 million * Q2 pretax profit USD -3.07 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%